Healthcare Royalty, Inc. Purchase Agreements
4 Contracts & Agreements
- Royalty Purchase Agreement, dated as of January 6, 2018, between Antigenics LLC and Healthcare Royalty Partners III, L.P., and certain affiliated funds identified therein (Filed With SEC on July 29, 2021)
- Royalty Purchase Agreement, dated as of January 6, 2018, between Antigenics LLC and Healthcare Royalty Partners III, L.P., and certain affiliated funds identified therein (Filed With SEC on July 1, 2021)
- Purchase and Sale Agreement, dated as of February 2, 2017, by and between Portola Pharmaceuticals and Entities Managed by Healthcare Royalty Management, LLC (Filed With SEC on July 1, 2021)
- Asset Purchase Agreement, dated July 7, 2020, between Harris FRC Acquisition, LP and Harris FRC Corporation (Filed With SEC on July 1, 2021)
